Pressemitteilungen

externe Meldungen

29.04.2019

Ascenion GmbH

BioVaria 2019, 8 - 9 May, Munich: Strong Line-up of Technologies, Speakers and Startups

MUNICH

 

Ascenion is proud to present a strong line-up of speakers, participants, technologies and startups. Decision makers from biotech, pharma and finance will come together in Munich to learn about commercially attractive academic inventions and initiate partnerships with research teams, entrepreneurs and technology transfer professionals from all over Europe.

 

Whether you are

a scout or business developer from the international biopharmaceutical industry looking for cutting-edge inventions to complement your companies’ R&D portfolios,

a life-science investor looking for attractive startups or IP assets as investment opportunities,

a technology transfer professional or scientist from public research institutions who has patent-protected technologies available for licensing or partnering,

 

then do not miss to register for BioVaria 2019 to be held on 8 – 9 May!

66 peer-selected, patent-protected technologies originating from as many research institutes, universities and university hospitals will be featured.

 

Further program highlights include a panel discussion on “From stem cells to therapy: Development of cell based approaches in regenerative medicine” and BioVaria’s dedicated Startup Pitch & Partner program which provides attractive opportunities for entrepreneurs and venture capitalists.

 

Preview BioVaria’s Technologies and Startups online

Explore the technologies presented in 10-min oral presentations and posters!

Get a first impression of the participating startups!

 

Register now at www.biovaria.org

 

Patron:

Bavarian Ministry of Economic Affairs, Regional Development and Energy

Sponsors:

BioM, Abbvie, Else Kröner-Fresenius-Stiftung, ISAR Bioscience, Johnson & Johnson Innovation, HERTIN & Partner, Kador & Partner, NLC, Vossius & Partner

Startup Sponsors:

24IP Law Group, Accelero Bioanalytics, Charles River, German Accelerator Life Sciences, IASON Consulting, K&L Gates, LSI Life Science Inkubator, LSP, ttopstart, TVM Capital Life Science

Technology transfer partners:

Ascenion, Austria Wirtschaftsservice Gesellschaft, BayPAT, DKFZ - German Cancer Research Center, DZIF - German Center for Infection Research, EMBLEM Technology Transfer, IOCB Tech, Lead Discovery Center, LMU Munich, Max Planck Innovation, Netval, PROvendis, TechnologieAllianz, University of Pardubice, VIS

Network partners:

ASTP-Proton, BIO Deutschland, BioRN

 

Media partners:

Business Wire, Going Public, LABIOTECH.eu, transkript

 

Contacts

Ascenion GmbH

Esther Lange

T: +49 (0)89 318814-22

lange@ascenion.de

 

Newsletter

Anmeldung

Archiv